High-fat diet alters immune cells in spleen, kidney and tumor and impacts the volume growth of renal cell carcinoma
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High-fat diet alters immune cells in spleen, kidney and tumor and impacts the volume growth of renal cell carcinoma
Authors
Keywords
-
Journal
International Immunopharmacology
Volume 124, Issue -, Pages 110982
Publisher
Elsevier BV
Online
2023-10-19
DOI
10.1016/j.intimp.2023.110982
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of overweight and obesity on the risk of hepatocellular carcinoma: a prospective cohort study in 14.3 million Koreans
- (2022) Baek Gyu Jun et al. BRITISH JOURNAL OF CANCER
- Leptin Signaling in Obesity and Colorectal Cancer
- (2022) Claudia Terezia Socol et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Familial Risk of Renal Cell Cancer and Interaction with Obesity and Hyperglycemia—A Population-Based Study
- (2022) Sung Won Lee et al. JOURNAL OF UROLOGY
- Endometrial cancer
- (2022) Emma J Crosbie et al. LANCET
- Review article: obesity and colorectal cancer
- (2022) Marc Bardou et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- New insights from the single-cell level: Tumor associated macrophages heterogeneity and personalized therapy
- (2022) Xiaomin Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- Implications of metabolic health status and obesity on the risk of kidney cancer: A nationwide population-based cohort study
- (2022) Yun Kyung Cho et al. Frontiers in Endocrinology
- A multicenter phase 2 single arm study of cabozantinib in patients with advanced or unresectable renal cell carcinoma pre-treated with one immune-checkpoint inhibitor: The BREAKPOINT trial (Meet-Uro trial 03)
- (2022) Giuseppe Procopio et al. TUMORI
- The role of immune dysfunction in obesity-associated cancer risk, progression, and metastasis
- (2021) Aneesha Kulkarni et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Mapping the immune environment in clear cell renal carcinoma by single-cell genomics
- (2021) Nicholas Borcherding et al. Communications Biology
- Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma
- (2021) Kevin Bi et al. CANCER CELL
- Implications of the obesity epidemic for endometrial cancer risk, mortality, and survivorship
- (2021) Ashley S. Felix et al. GYNECOLOGIC ONCOLOGY
- Multi-tissue single-cell analysis deconstructs the complex programs of mouse natural killer and type 1 innate lymphoid cells in tissues and circulation
- (2021) Adelle P. McFarland et al. IMMUNITY
- Metabolic pathways in obesity-related breast cancer
- (2021) Kristy A. Brown Nature Reviews Endocrinology
- The Impact of obesity and diabetes mellitus on pancreatic cancer: Molecular mechanisms and clinical perspectives
- (2020) Bao Quoc Lam et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma
- (2020) David A. Braun et al. NATURE MEDICINE
- Obesity and esophageal cancer: GERD, Barrett´s esophagus, and molecular carcinogenic pathways
- (2020) Francisco Schlottmann et al. Expert Review of Gastroenterology & Hepatology
- Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long‐term follow‐up of the randomized, open‐label, phase 3 CheckMate 025 trial
- (2020) Robert J. Motzer et al. CANCER
- Immunomodulatory Roles of VEGF Pathway Inhibitors in Renal Cell Carcinoma
- (2020) Laure Hirsch et al. DRUGS
- Weighing the Risk: effects of Obesity on the Mammary Gland and Breast Cancer Risk
- (2020) Lauren E. Hillers-Ziemer et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- NK cells and ILCs in tumor immunotherapy
- (2020) Simona Sivori et al. MOLECULAR ASPECTS OF MEDICINE
- Natural killer cells in cancer biology and therapy
- (2020) Song-Yang Wu et al. Molecular Cancer
- Physical activity, obesity and sedentary behavior in cancer etiology: epidemiologic evidence and biologic mechanisms
- (2020) Christine M. Friedenreich et al. Molecular Oncology
- Obesity as a risk factor for thyroid cancer
- (2020) Antonio Matrone et al. Current Opinion in Endocrinology Diabetes and Obesity
- Colorectal Cancer, Age, and Obesity-Related Comorbidities: A Large Database Study
- (2020) Abbinaya Elangovan et al. DIGESTIVE DISEASES AND SCIENCES
- CAR-NK cells: A promising cellular immunotherapy for cancer
- (2020) Guozhu Xie et al. EBioMedicine
- Effect of Metabolic Health and Obesity Phenotype on the Risk of Pancreatic Cancer: A Nationwide Population-Based Cohort Study
- (2020) Hye Soo Chung et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor Immunity
- (2020) Alison E. Ringel et al. CELL
- High-Fat Diet and Feeding Regime Impairs Number, Phenotype, and Cytotoxicity of Natural Killer Cells in C57BL/6 Mice
- (2020) Julia Spielmann et al. Frontiers in Nutrition
- Patient-reported outcomes of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib (CheckMate 214): a randomised, phase 3 trial
- (2019) David Cella et al. LANCET ONCOLOGY
- IL-15 by continuous i.v. infusion to adult patients with solid tumors in a Phase I trial induced dramatic NK cell subset expansion
- (2019) Kevin C Conlon et al. CLINICAL CANCER RESEARCH
- Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial
- (2019) Brian I Rini et al. LANCET
- Vascular endothelial growth factor and programmed death‐1 pathway inhibitors in renal cell carcinoma
- (2019) Charlene M. Mantia et al. CANCER
- Excess Body Weight and the Risk of Liver Cancer: Systematic Review and a Meta-Analysis of Cohort Studies
- (2019) Chao Yang et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control
- (2018) Jan P. Böttcher et al. CELL
- Innate Lymphoid Cells: Diversity, Plasticity, and Unique Functions in Immunity
- (2018) Marco Colonna IMMUNITY
- Metabolic Barriers to T Cell Function in Tumors
- (2018) Ayaka Sugiura et al. JOURNAL OF IMMUNOLOGY
- The multifaceted contributions of mitochondria to cellular metabolism
- (2018) Jessica B. Spinelli et al. NATURE CELL BIOLOGY
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- OUP accepted manuscript
- (2018) Advances in Nutrition
- Cancer Statistics for Hispanics/Latinos, 2018
- (2018) Kimberly D. Miller et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Spatial and temporal coordination of antiviral responses by group 1 ILCs
- (2018) Nicholas M. Adams et al. IMMUNOLOGICAL REVIEWS
- Safety and Efficacy of Nivolumab in Combination With Ipilimumab in Metastatic Renal Cell Carcinoma: The CheckMate 016 Study
- (2017) Hans J. Hammers et al. JOURNAL OF CLINICAL ONCOLOGY
- The Emerging Hallmarks of Cancer Metabolism
- (2016) Natalya N. Pavlova et al. Cell Metabolism
- Diversity and function of group 1 innate lymphoid cells
- (2016) Victor S. Cortez et al. IMMUNOLOGY LETTERS
- Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Toni K. Choueiri et al. NEW ENGLAND JOURNAL OF MEDICINE
- IL-2: The First Effective Immunotherapy for Human Cancer
- (2014) S. A. Rosenberg JOURNAL OF IMMUNOLOGY
- Adjuvant Low-Dose Interleukin-2 (IL-2) Plus Interferon-α (IFN-α) in Operable Renal Cell Carcinoma (RCC)
- (2014) Rodolfo Passalacqua et al. JOURNAL OF IMMUNOTHERAPY
- Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cells
- (2014) Dorothy K Sojka et al. eLife
- The GNB3 C825T polymorphism as a pharmacogenetic marker in the treatment of hypertension, obesity, and depression
- (2011) Stefanie Klenke et al. Pharmacogenetics and Genomics
- The application of high-dose interleukin-2 for metastatic renal cell carcinoma
- (2009) David F. McDermott MEDICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started